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Materials and methods
Chemicals and reagents
Silver nitrate (AgNO3), silver sulfadiazine (AgSD) and trisodium citrate were purchased 
from Sigma-Aldrich. 2-Hydroxy-1-[4-(2-hydroxyethoxy)phenyl]- 2-methyl-1-
propanone (I-2959) was a generous gift from BASF. 
Synthesis of LL37
A modified LL-37 peptide, CSG-LLGDFFRKSKEKIGKEFKRIVQRIKDFLRNLVPRTES-
NH2, was synthesized on a Symphony automated peptide synthesizer (Protein Technologies 
Inc., Tucson, AZ, U.S.A.) using standard fluorenylmethoxycarbonyl (Fmoc) chemistry.  HCTU 
(ChemPep Inc., Wellington, FL, USA) was used as the activating reagent. The 0.1 mmol scale 
synthesis used Fmoc-PAL-PS resin (Applied Biosystems, Life Technologies Europe BV, 
Sweden) and four-fold excess of amino acids in each coupling. The resultig peptides were 
cleaved from the resin by treatment with a mixture of trifluoroacetic acid (TFA), water and 
triisopropylsilane (TIS) (95:2.5:2.5 v/v; 10 mL per gram of polymer) for 2 h at ambient 
temperature.  They were then filtered and the TFA was evaporated. The LL37 was then 
precipitated by the addition of cold diethyl ether, centrifuged and lyophilized. Purification was 
done using reversed-phase HPLC on a semi-preparative C-18 column (Grace Vydac, 
Helsingborg, Sweden) and peptide identity was confirmed by their MALDI-TOF spectra (M+1 
4741).
Synthesis of LL37@AgNP and citrate@AgNP
Citrate@AgNPs were prepared from deoxygenated (30 min) 0.2 mM AgNO3, 0.2 mM 
I-2959, and 1.0 mM sodium citrate irradiated with UVA light (8 lamps, in a Luzchem 
CCP-V4 photoreactor at 25.0 ± 0.5°C). A similar procedure was used for preparing 
LL37-coated AgNPs (LL37@AgNPs) but in this case sodium citrate was replaced by a 
solution of 2.5 μM LL37. The methodology is based on the Norrish Type I 
photocleavage of I-2959 leading to ketyl radicals with a quantum efficiency of 0.29,1 
which acts as a reducing agent, reducing in this case, Ag+ to Ag°.2-4 The reaction 
evolution was monitored at the plasmon absorption band. Absorbance spectra were 
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recorded using a Cary-100-Bio UV–Vis spectrophotometer (Varian) at a scan speed of 
1515 nm/min at room temperature, employing 0.7 cm pathlength cuvettes.
TEM images, dynamic light scattering, and zeta potential measurements
Samples for electron microscopy were prepared by delivering ~10 μl of solution to 
carbon-coated copper grids (400 mesh) and dried in a vacuum system. Electron 
microscopy images were obtained in a JSM-7500F FESEM from JEOL Inc., operating 
in the transmission mode (TEM). Nanoparticle sizes were calculated from TEM 
imaging by using ImageJ software.5 The zeta potential and hydrodynamic sizes were 
measured in a Malvern Zetasizer Nano ZS, using 1.0 cm pathlength disposable cuvettes 
and disposable 0.5 ml folded capillary cells (from Malvern) for DLS and zeta potential, 
respectively.
Biocompatibility and cell proliferation experiments
The cytotoxicity of LL37@AgNPs and citrate@AgNPs was evaluated in vitro using low 
passage (<8) primary human dermal fibroblasts (ATCC, USA). The fibroblasts were 
grown in Dulbecco’s modified eagle’s medium (DMEM, Gibco Life Technologies, 
Burlington, Canada) containing 10% fetal calf serum and 1.0 % penicillin/streptomycin, 
and cultured at 37°C, 5.0 % CO2, and 100 % humidity. Cell viability was evaluated 
using CellTiter 96® Aqueous MTS colorimetric viability assay (Promega) and employed 
as a measure of cell survival after 14 h of incubation. Briefly, from confluent fibroblasts 
cultured, 100 µl of a 5 x 104 cells/ml solution were seeded in a 96-well plate followed 
by overnight incubation, prior to addition of nanoparticles, AgSD or AgNO3. After 14 h 
of sample incubation, the well contents were replaced by 100 μl fresh cell culture 
medium and 20 μl of MTS solution, and wells were incubated for 2 h. The absorbance 
at 490 nm was measured in a 96-well plate in a SpectraMax 5 from Molecular Devices 
and viable cells were plotted as % of cell survival. Cell proliferation experiments were 
performed in 96-well plates, where 100 µl of a 1 x 104 cells/ml solution were seeded in 
each well. After overnight incubation, solutions of nanoparticles, AgSD and AgNO3 in 
DMEM were added, and replaced every 48 h. Pictures were taken every 24 h with a 
JuLI Microscope and cells were counted with ImageJ and refered to cells/cm2.
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Live/Dead® experiments
The Live/Dead® kit for mammalian cells (Invitrogen L-3244, Carlsbad, CA) was 
employed to further gather information regarding the effect of the different silver 
sources on cultures of human skin fibroblasts. The cells were seeded in 8 well chambers 
Lab-Tek (Thermo Scientific, Nunc) borosilicate sterile wells at a density of ≈ 3500 
cells/cm2, same density used for the MTS and cell proliferation counting experiments 
described above. After an overnight incubation, solutions of nanoparticles, AgSD and 
AgNO3 in DMEM were added to the chambers and the cells incubated for different tive 
intervals as shown in Figure 3B. Prior to staining and cell counting, the cells were 
washed out with PBS and incubated in 4 μM ethidium, 2 μM calcein solution for 3.0 
min in dark. Fluorescence images were obtained in a Zeiss Observer A1 Fluorescence 
Inverted Microscope using a 10X planar objective. The experiments were carried out by 
duplicated. The cells were counted under the microscope and the numbers shown in 
Figure 3B, correspond to the average of at least 4 different regions in a well.
Flow cytometry experiments
Flow cytometry experiments were also carried out to further gather information 
regarding the operative cell death mechanism of human skin fibroblasts incubated with 
the different silver sources. Briefly, human skin fibroblasts were culture in 150 cm2 cell 
culture bottles (at ≈ 3500 cells/cm2, ≈ 5x105 cells/bottle) for 14h and the corresponding 
silver sources in DMEM, or pure DMEM for the control, added. After 12h of incubation 
the cells were trypsinated, counted and suspensions of 1x106 cells/ml prepared. Those 
suspensions were stained with Alexa Fluor®488 annexin V/Dead cell apoptosis kit 
(V13241, Molecular Probes) following the recommendations of the provider 
(http://www.lifetechnologies.com/order/catalog/product/V13241). The cells were then 
analyzed in a Beckman-Coulter FC500 flow cytometer using 488 nm laser excitation 
and 525±25 and 575±25 nm detection channels for apoptosis and necrosis, respectively.
Antimicrobial activity
The antimicrobial properties of the LL37@AgNPs, citrate@AgNPs, AgSD and AgNO3 
were assessed against the gram (-) E. coli (CF073) and P. aeruginosa (PA14) as well as 
the gram (+) S. epidermidis (SE19) and S. aureus (ATTC 25923). The Minimal 
inhibitory concentration (MIC) was determined by the broth microdilution method, 
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slightly modified from the standard Clinical and Laboratory Standards Institute (CLSI) 
protocol.6 An overnight culture from a single colony of each bacterium was diluted to a 
cell density of ~105 cfu/ml in Luiria Bertani (LB) broth that contained a two-fold 
dilution of the test compound. The absorbance was estimated at 630 nm measured at 
time 0 and after 18 h of incubation at 37°C. The lowest concentration of test-substance 
at which the absorbance of the bacterial inoculum did not increase substantially 
(ΔOD630 < 0.03 OD units/18 h) was taken as the MIC. All measurements were carried 
out in triplicate, on two independent days and median results were reported. For the 
time kill assay, exponentially growing cultures of each of the four bacterial strains were 
exposed for 3 to12 h in 96-well plates, to 2XMIC concentrations of each test substance 
while constantly stirred at 37°C. Estimates of the density of surviving bacteria were 
obtained by plating saline-diluted samples on LB agar and allowing for growth at 37°C 
for 18-24 h. The ensuing colonies were counted manually. 
Biofilm formation
2.0 mL of LL37@AgNP, LL37 0.156 µM or water were added into 6 well tissue culture 
plates (Costar) under sterile conditions. The plates were then incubated at 37ºC, 90% 
humidity for 24h and employed to asses biofilm formation using a modified air liquid 
interface (ALI) assay: 7 Saturated overnight cultures were diluted 1/100 into a minimal 
medium (M63-arginine) made up of M63 salts (1% potassium phosphate [monobasic] 
and 0.2% ammonium sulfate) supplemented with arginine (0.4%) and MgSO4 (1 mM). 
8 The diluted cultures were added to the wells of angled (30º) 6-well plates, followed by 
the incubation at 37oC for 16 h. After removing the culture from the wells and 
extensively washing with 0.9% NaCl, the biofilms were analyzed on an inverted 
microscope by phase-contrast microscopy.
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Figure S1. Changes on AgNP-SPB absorption at 395 nm measured as function of the 
irradiation time for a sample containing 0.2 mM AgNO3, 0.2 mM I-2959 and 2.5 µM 
LL37 peptide. The red arrow indicates the addition of another extra 0.2 mM I-2959. 
Note that there is no further increment in the absorbance which suggests that all the 
available Ag+ has already been reduced. All the measurements were carried out in free 
oxygen solutions at room temperature under UVA irradiation, see experimental. 
Figure S2. Changes on AgNP-SPB represented as A/A0 at their maxima absorption 
measured at different time intervals after addition into LB or DMEM media. The 
samples were kept at 37ºC. All measurements were carried out at room temperature. 
10% arbitrary error bars have been included for comparison purposes. 
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Figure S3. Number of survival bacteria colonies counted in the presence of 0.156 µM 
LL-37 peptide which corresponds to ≈ 12.5 µM Ag measured for the different bacteria 
strains as E. coli (), P. aeruginosa (), S. epidermidis (), and S. aureus (). All 
experiments were carried out in 25% LB and colonies counted after 18 h of incubation 
at 37ºC on LB agar plates.
Figure S4. Human skin fibroblasts cell toxicity in the presence of different silver 
sources measured after 14 h incubation using MTS colorometric assay. Error bars 
correspond to SD obtained from three samples.
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Figure S5. Effect of LL37@AgNPs at 6.25 µM silver concentration on the proliferation 
profile of human skin fibroblasts. The LL37@AgNP solution was changed every 48 h. 
Error bars correspond to SD from six different samples obtained from triplicate 
experiments. Two tail t-Student test, p>0.5.
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Figure S6. Effect of AgSD and AgNO3 at 6.25 µM silver concentration on the 
proliferation profile of human skin fibroblasts in the presence of 0.078 µM LL37 
peptide. The solutions of Ag and LL37 were changed every 48 h. Error bars correspond 
to SD from six different samples obtained from triplicate experiments.
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Figure S7. Representative flow cytometry profiles for human skin fibroblasts (≈1x106 
cells/ml) stained with Alexa Fluor®488 annexin V/Dead cell apoptosis kit for control 
samples (left) or incubated with AgSD (right). C1 and C2 correspond to the regions 
where propidium iodide fluoresces and can be interpreted as necrotic cells while C4 is 
the green channel where apoptotic cells would appear. Unstained cells are contained in 
C3 and correspond to viable human skin cells.
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